Sign in

CIK 0001422143

  • Non-accelerated filer
  • Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547851
Phone
+1 858-500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
Open-market buys, last 90 days
$4,248,530
in 3 filings
Open-market sales, last 90 days
$1,929,830
in 12 filings, $348K under 10b5-1 plans

Net +$2,318,700. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 38 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-04 VASCONCELLES MICHAEL Director Grant or award · Option to purchase common stock +35,000 35,000
2025-06-05 VASCONCELLES MICHAEL Director Grant or award · Option to purchase common stock +28,500 28,500
2024-09-13 VASCONCELLES MICHAEL Director Grant or award · Option to purchase common stock +52,000 52,000
2024-09-13 VASCONCELLES MICHAEL Director Grant or award · Option to purchase common stock +17,333 17,333

Page 1 of 1 · 4 trades